drugset

drugset / Trial / NCT06659757

A Study to Investigate the Safety and Tolerability of Single and Multiple Ascending Doses of KIT2014 in Healthy Subjects

NCT06659757 ↗

Phase 1 Completed 56 enrolled Kither Biotech Srl Avance Clinical Pty Ltd. · collab

RandomizedSequentialDouble-blindTreatment

Summary

This is the first-in-human study with KIT2014 designed to provide safety, tolerability and pharmacokinetic data in healthy volunteers.

Timeline

Start: 2024-10-16
Primary completion: 2025-07-14
Completion: 2025-07-14

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	KIT2014	Unknown	—	Inhaled

Indications